Table 3 FSFI scores in 50 patients affected by idiopathic OAB symptoms and sexuadysfunction, before and 12 weeks after treatment with oral Mirabegron, 50 mg/day
From: The impact of Mirabegron on sexual function in women with idiopathic overactive bladder
FSFI domains | Baseline (mean ± SD) | 12-weeks f-up (mean ± SD) | p value |
|---|---|---|---|
Desire | 3.03 ± 0.65 | 3.51 ± 0.88 | 0.04 |
Arousal | 2.87 ± 0.61 | 3.35 ± 0.94 | < 0.0001 |
Lubrication | 3.31 ± 0.72 | 3.93 ± 1.06 | 0.0008 |
Orgasm | 3.36 ± 0.74 | 3.80 ± 0.96 | 0.0001 |
Satisfaction | 3.33 ± 0.91 | 4.04 ± 1.05 | 0.0008 |
Pain | 3.24 ± 0.88 | 3.52 ± 0.93 | 0.58 |
Total FSFI score | 18.9 ± 4.3 | 21.9 ± 4.5 | < 0.0001 |